105 related articles for article (PubMed ID: 4263686)
1. Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
Lott IT; Murphy DL; Chase TN
Neurology; 1972 Sep; 22(9):967-72. PubMed ID: 4263686
[No Abstract] [Full Text] [Related]
2. Catabolism of serotonin in Down's syndrome (tisomy 21).
Kamoun P; Lafourcade G; Jerome H
Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
[No Abstract] [Full Text] [Related]
3. Central monoamine metabolism in Parkinson's disease.
Chase TN; Ng LK
Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
[No Abstract] [Full Text] [Related]
4. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Papeschi R; Molina-Negro P; Sourkes TL; Erba G
Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
[No Abstract] [Full Text] [Related]
5. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
Airaksinen EM
J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
[No Abstract] [Full Text] [Related]
6. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
Tu J; Partington MW
Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
[No Abstract] [Full Text] [Related]
7. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
Johansson B; Roos BE
Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
[No Abstract] [Full Text] [Related]
8. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
9. Defective binding of 5-HT by blood platelets from children with the trisomy 21 form of Down's syndrome.
Boullin DJ; Coleman M; O'Brien RA
J Physiol; 1969 Oct; 204(2):128P+. PubMed ID: 4241928
[No Abstract] [Full Text] [Related]
10. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
Pind K; Faurbye A
Acta Psychiatr Scand; 1970; 46(4):323-6. PubMed ID: 4323062
[No Abstract] [Full Text] [Related]
11. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
Bowers MB
Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
[No Abstract] [Full Text] [Related]
12. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-dopa.
Mendell JR; Chase TN; Engel WK
Trans Am Neurol Assoc; 1971; 96():284-6. PubMed ID: 5159109
[No Abstract] [Full Text] [Related]
13. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
14. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
15. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
16. Diminished activity of platelet monoamine oxidase in Down's syndrome.
Benson PF; Southgate J
Am J Hum Genet; 1971 Mar; 23(2):211-4. PubMed ID: 4253914
[No Abstract] [Full Text] [Related]
17. 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
Gordon EK; Oliver J
Clin Chim Acta; 1971 Nov; 35(1):145-50. PubMed ID: 4256760
[No Abstract] [Full Text] [Related]
18. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
Gottfires CG; Roos BE
Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
[No Abstract] [Full Text] [Related]
19. Biogenic amines in 47, XYY syndrome.
Bioulac B; Benezech M; Renaud B; Roche D; Noël B
Neuropsychobiology; 1978; 4(6):366-70. PubMed ID: 692839
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome: transport, storage, and metabolism of serotonin in blood platelets.
Lott IT; Chase TN; Murphy DL
Pediatr Res; 1972 Sep; 6(9):730-5. PubMed ID: 4264688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
